Ironwood Pharma reports February 12

• Ironwood Pharmaceuticals (NASDAQ:IRWD) will report Q4 and full-year results on February 12 after the close. The conference call will begin at 4:30 pm ET.
• Consensus views for Q4 and 2014 are losses per share of ($0.21) and ($1.32) on revenues of $36.6M and $73.7M, respectively.